Numenos
Numenos is a biotechnology company focused on accelerating drug development through AI-driven Foundation Models. Their CURE platform integrates and analyzes real-world and clinical trial data to uncover causal and predictive biomarkers, identify unmet medical needs, and prioritize drug assets for multiple indications. By leveraging a proprietary foundation model with over 100 million parameters, Numenos aims to reveal the real benefits of experimental drugs on an individual patient level, leading to earlier success signals, reduced trial sizes by 50-70%, and a potential 10x increase in trial significance. The company consists of entrepreneurs, biologists, physicists, and AI specialists with extensive experience in AI, Pharma, R&D, and clinical trial strategy.
Numenos
Numenos is a biotechnology company focused on accelerating drug development through AI-driven Foundation Models. Their CURE platform integrates and analyzes real-world and clinical trial data to uncover causal and predictive biomarkers, identify unmet medical needs, and prioritize drug assets for multiple indications. By leveraging a proprietary foundation model with over 100 million parameters, Numenos aims to reveal the real benefits of experimental drugs on an individual patient level, leading to earlier success signals, reduced trial sizes by 50-70%, and a potential 10x increase in trial significance. The company consists of entrepreneurs, biologists, physicists, and AI specialists with extensive experience in AI, Pharma, R&D, and clinical trial strategy.